n | Mean | SD | Min | Max | |
---|---|---|---|---|---|
M0—preop (seated patient) | |||||
SE | 48 | −0.82 | 3.11 | −10.15 | 4.88 |
Sphere | 48 | −0.25 | 3.13 | −9.81 | 5.44 |
Cylinder | 48 | −1.14 | 0.98 | −4.38 | −0.15 |
J0 | 48 | −0.35 | 0.78 | −1 | 1.98 |
J45 | 48 | −0.07 | 0.35 | −1.1 | 1.13 |
B | 48 | 2.75 | 1.89 | 0.37 | 10.15 |
M1—speculum | |||||
SE | 52 | −0.65 | 2.73 | −7.36 | 5.11 |
Sphere | 52 | 0.11 | 2.76 | −6.22 | 5.42 |
Cylinder | 52 | −1.51 | 1.14 | −4.85 | 0 |
J0 | 52 | −0.14 | 0.74 | −1 | 1.42 |
J45 | 52 | −0.07 | 0.67 | −1.88 | 1.82 |
B | 52 | 2.45 | 1.67 | 0.02 | 7.45 |
M2—CCI | |||||
SE | 44 | −0.53 | 2.97 | −8.03 | 5.5 |
Sphere | 44 | 0.24 | 2.96 | −7.61 | 6.04 |
Cylinder | 44 | −1.55 | 1.13 | −4.28 | −0.22 |
J0 | 44 | −0.17 | 0.79 | −1 | 1.9 |
J45 | 44 | −0.14 | 0.64 | −2.13 | 1.32 |
B | 44 | 2.69 | 1.67 | 0.35 | 8.04 |
M3—OVD | |||||
SE | 35 | −0.22 | 3.09 | −6.35 | 7.37 |
Sphere | 35 | 0.7 | 3.21 | −6.15 | 8.61 |
Cylinder | 35 | −1.83 | 1.2 | −4.74 | −0.21 |
J0 | 35 | −0.2 | 0.73 | −1 | 1.83 |
J45 | 35 | −0.12 | 0.77 | −2.13 | 1.23 |
B | 35 | 2.76 | 1.7 | 0.54 | 7.48 |
M4—aphakia | |||||
SE | 55 | 14.03 | 2.23 | 7.56 | 18.2 |
Sphere | 55 | 15.01 | 2.16 | 9.66 | 18.64 |
Cylinder | 55 | −1.96 | 1.2 | −4.28 | −0.12 |
J0 | 55 | 0.01 | 0.78 | −1 | 1.89 |
J45 | 55 | −0.03 | 0.87 | −1.95 | 1.72 |
B | 55 | 14.08 | 2.22 | 7.63 | 18.23 |
M5—aphakia+OVD 1/3 | |||||
SE | 63 | 13.4 | 2.51 | 5.27 | 17.1 |
Sphere | 63 | 14.2 | 2.6 | 5.61 | 19.13 |
Cylinder | 63 | −1.6 | 1.09 | −4.78 | −0.11 |
J0 | 63 | 0.01 | 0.73 | −1 | 1.93 |
J45 | 63 | −0.05 | 0.68 | −2.27 | 1.73 |
B | 63 | 13.44 | 2.51 | 5.28 | 17.17 |
M6—aphakia+OVD 2/3 | |||||
SE | 36 | 12.51 | 3.73 | −2.29 | 16.9 |
Sphere | 36 | 13.26 | 3.45 | −0.17 | 17.16 |
Cylinder | 36 | −1.51 | 1.01 | −4.23 | −0.26 |
J0 | 36 | 0.03 | 0.77 | −1 | 1.89 |
J45 | 36 | −0.02 | 0.48 | −0.78 | 1.49 |
B | 36 | 12.68 | 3.22 | 2.5 | 16.9 |
M7—aphakia+OVD 3/3 | |||||
SE | 29 | 12.91 | 2.66 | 7.65 | 17.25 |
Sphere | 29 | 13.61 | 2.59 | 8.55 | 18.05 |
Cylinder | 29 | −1.41 | 0.79 | −3.51 | −0.17 |
J0 | 29 | 0.14 | 0.72 | −0.91 | 1.71 |
J45 | 29 | −0.16 | 0.43 | −0.9 | 0.67 |
B | 29 | 12.94 | 2.64 | 7.7 | 17.27 |
M8—pseudophakia | |||||
SE | 40 | −1.54 | 2.44 | −5.69 | 9.69 |
Sphere | 40 | −0.64 | 2.39 | −4.34 | 10.54 |
Cylinder | 40 | −1.78 | 1.01 | −4.83 | −0.31 |
J0 | 40 | 0.21 | 0.8 | −1 | 1.84 |
J45 | 40 | 0.01 | 0.66 | −1.95 | 1.9 |
B | 40 | 2.51 | 1.74 | 0.44 | 9.73 |
M9—pseudophakia—OVD 1/3 | |||||
SE | 53 | −2.44 | 1.75 | −8.8 | −0.38 |
Sphere | 53 | −1.59 | 1.75 | −7.87 | 1.2 |
Cylinder | 53 | −1.7 | 0.87 | −3.79 | −0.23 |
J0 | 53 | −0.01 | 0.79 | −1 | 1.87 |
J45 | 53 | 0.12 | 0.57 | −1.42 | 1.19 |
B | 53 | 2.71 | 1.63 | 0.73 | 8.85 |
M10—pseudophakia—OVD 2/3 | |||||
SE | 27 | −3.18 | 2.08 | −7.24 | 1.85 |
Sphere | 27 | −2.18 | 2.06 | −6.15 | 2.09 |
Cylinder | 27 | −2 | 1.1 | −4.98 | −0.34 |
J0 | 27 | 0.31 | 0.89 | −1 | 2.48 |
J45 | 27 | 0.13 | 0.66 | −0.91 | 1.79 |
B | 27 | 3.55 | 1.75 | 0.92 | 7.32 |
M11—pseudophakia—OVD 3/3 | |||||
SE | 23 | −2.83 | 2.23 | −6.94 | 2.05 |
Sphere | 23 | −2.03 | 2.18 | −5.81 | 2.54 |
Cylinder | 23 | −1.6 | 0.93 | −4.84 | −0.33 |
J0 | 23 | −0.15 | 0.85 | −1 | 2.41 |
J45 | 23 | 0.05 | 0.53 | −1.11 | 1 |
B | 23 | 3.25 | 1.83 | 0.75 | 7.03 |
M12—postop day 1 (seated patient) | |||||
SE | 46 | −1.49 | 0.99 | −4.13 | 0.27 |
Sphere | 46 | −0.92 | 1.01 | −3.64 | 1.09 |
Cylinder | 46 | −1.14 | 0.72 | −3.92 | −0.19 |
J0 | 46 | −0.32 | 0.67 | −1 | 1.28 |
J45 | 46 | −0.04 | 0.37 | −0.71 | 1.06 |
B | 46 | 1.77 | 0.85 | 0.34 | 4.25 |
J0, J45, Jackson cross cylinder at 0° and 45°; B, blurring strength11=. n Differs across measurement points because not every measurement succeeded. Note that the preoperative and postoperative data was taken under standardised conditions in physiological mydriasis with the WASCA Analyser (see ref. 8 for more details) while the patient was seated, whereas all other readings were recorded during surgery with the patient on his or her back.
CCI, clear corneal incision; OVD, ophthalmic viscosurgical device; SE, spherical equivalent; WASCA, wavefront supported custom ablation.